BioSpace News Archive

A pre-specified exploratory analysis from the SURPASS-4 trial showed tirzepatide, a novel once-weekly medication for the treatment of diabetes, improved kidney outcomes for adults with type 2 diabetes who have increased cardiovascular risk.

Findings from two studies funded by the ADA Pathway to Stop Diabetes research program highlight innovative science and the latest diabetes developments on genomic profiling and glucose control.

According to Nova one advisor, during the forecast period of 2022 to 2030, the global Solitary Fibrous Tumor Treatment market is estimated to develop at a compound annual growth rate (CAGR) of 4.5%.

Arcutis Biotherapeutics, Inc. reported the grant of an aggregate of 24,000 restricted stock units of Arcutis’ common stock as well as options to purchase an aggregate of 64,900 shares of Arcutis’ common stock to seven newly hired employees.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced encouraging preliminary safety and efficacy results from its Phase 1B study of unesbulin (PTC596) in advanced leiomyosarcoma (LMS) patients.

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to 24 new employees.

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced that Vu Truong , Ph.D., Chief Executive Officer of Aridis Pharmaceuticals, will participate in a virtual fireside chat presented by Maxim Group LLC and hosted by M-Vest on June 7 at 11 a.m. ET.

New data from Daiichi Sankyo’s (TSE: 4568) patritumab deruxtecan (HER3-DXd) showed clinically meaningful and durable responses in two early-stage trials in previously treated patients with HER3 expressing metastatic breast cancer or advanced non-small cell lung cancer (NSCLC) without EGFR-activating mutations.

Ms. Weymer has 20 years of clinical research and drug development experience in both biotech and CRO roles, comprising early to late-stage clinical development.

Dxcover test could have a significant impact on early detection of cancer, vital for improved survival and quality of life.